Acthar Gel (Repository corticotropin hormone) for Rheumatoid Arthritis | myRAteam

Connect with others who understand.

sign up Log in
About myRAteam
Powered By

Acthar Gel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat rheumatoid arthritis. Acthar Gel is also referred to by its drug name, repository corticotropin hormone injection.

Acthar Gel is an adrenocorticotropic hormone (ACTH) analogue. Acthar Gel is believed to work by stimulating the body to produce corticosteroid hormones that help control inflammation.

How do I take it?
Prescribing information states that Acthar Gel is usually administered as a subcutaneous or intramuscular injection.

Side effects
The FDA-approved label for Acthar Gel lists common side effects including fluid retention, changes in glucose tolerance, high blood pressure, behavioral and mood changes, increased appetite, and weight gain.

Rare but serious side effects listed for Acthar Gel include adrenal insufficiency, a disorder of blood cortisol levels known as Cushing’s syndrome, stomach and intestinal damage, severe depression, psychosis, eye disorders such as glaucoma or cataracts, loss of bone density, and increased risk of infection.

For more details about this treatment, visit:

Acthar Gel — Mallinckrodt

H.P. Acthar Gel — RxList

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in